This inventor holds 14 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Poviva Corp.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Innovations by Inventor John Docherty in Diabetes and Epilepsy Treatments
Introduction
John Docherty, an accomplished inventor based in Port Perry, Canada, has made significant contributions to the fields of medical treatments, particularly concerning diabetes and epilepsy. With a portfolio of 12 patents, Docherty's work exemplifies the intersection of innovation and healthcare.
Latest Patents
Among his latest patents, Docherty has developed groundbreaking compositions and methods for treating diabetes. These innovations include the use of GLP-1 agonists, which are effective not only for treating diabetes but also for aiding in weight loss and improving cholesterol and triglyceride levels. He has disclosed methods targeting type-2 diabetes specifically, focusing on lowering A1C levels, body mass, and regulating incretin hormone levels.
In addition to his work on diabetes, Docherty has created compositions and methods for treating epilepsy. These medications are designed for oral delivery and include cannabidiol and CBD-containing compositions tailored for individuals requiring treatment for epilepsy. His approach also encompasses kits that facilitate the delivery of these compositions.
Career Highlights
John Docherty is affiliated with Poviva Corp, a company known for its innovative healthcare solutions. Throughout his career, Docherty has been dedicated to developing effective treatment methods that improve patients' quality of life. His ability to merge scientific knowledge with practical applications has established him as a key figure in the industry.
Collaborations
Throughout his endeavors, Docherty has collaborated with notable colleagues, including Christopher Andrew Bunka and Thomas James Ihrke. Together, they have contributed to research and development initiatives that push the boundaries of medical technology and treatment methodologies.
Conclusion
John Docherty's innovations in diabetes and epilepsy treatments underscore his commitment to enhancing healthcare through invention. With a robust portfolio of patents and collaborative efforts, he continues to make significant strides in the medical field, showcasing the importance of innovation in addressing critical health issues.